Log in
Enquire now
Hyperion Therapeutics

Hyperion Therapeutics

A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Acquirer
Horizon Therapeutics
Horizon Therapeutics
0
AngelList URL
angel.co/hyperion-therapeutics
B2X
B2B
B2B
CAGE Code
6UTG6
0
CEO
‌
Mark Blumling
CIK Number
1,386,858
0
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...hyperion
Date Incorporated
2006
DUNS Number
807130500
0
Facebook URL
@HorizonTherapeutics
Founded Date
2007
0
Founder
‌
Mark Blumling
Glassdoor ID
909263
Industry
Biology
Biology
Healthcare
Healthcare
Therapeutics
Therapeutics
Biopharmaceutical
Biopharmaceutical
Drug discovery
Drug discovery
‌
Rare disease
Therapy
Therapy
Technology
Technology
Biotechnology
Biotechnology
Investors
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
Highland Capital Partners
Highland Capital Partners
WRF Capital
WRF Capital
IRS Number
611,512,713
0
Latest Funding Round Date
April 18, 2011
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/hyperion-therapeutics
Location
South San Francisco, California
South San Francisco, California
United States
United States
Patents Assigned (Count)
2
Pitchbook URL
pitchbook.com/profiles.../51327-37
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,834
0
Total Funding Amount (USD)
117,471,998
Official Website
hyperiontx.com
Wellfound ID
hyperion-therapeutics

Find more companies like Hyperion Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.